Stockreport

Nontuberculous Mycobacterial Infection Market to Exhibit Growth at a CAGR of 13.4% in the US by 2034 | DelveInsight

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF The nontuberculous mycobacterial infection market size shall grow during the forecast period (2024–2034) due to the launch of upcoming therapies and the increasing cases [Read more]